SNCA Antikörper (AA 1-140)
Kurzübersicht für SNCA Antikörper (AA 1-140) (ABIN364317)
Target
Alle SNCA Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 1-140
-
Spezifität
- NAC domain of alpha-synuclein (aa 61-95)
-
Aufreinigung
- Protein G purified
-
Immunogen
-
Recombinant human kappa-synuclein (1-140) purified from E. coli.
Type of Immunogen: Recombinant protein -
Isotyp
- IgG1 kappa
-
-
-
-
Applikationshinweise
-
Approved: ELISA, IHC, IHC-P (10 μg/mL), WB (1:500 - 1:2000)
Usage: Immunohistochemistry: This antibody was validated for use in immunohistochemistry on a panel of 21 formalin-fixed, paraffin-embedded (FFPE) human tissues after heat induced antigen retrieval in pH 6.0 citrate buffer. After incubation with the primary antibody, slides were incubated with biotinylated secondary antibody, followed by alkaline phosphatase-streptavidin and chromogen. The stained slides were evaluated by a pathologist to confirm staining specificity. The optimal working concentration for this antibody was determined to be 10 μg/mL. -
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- PBS, pH 7.4, 0.1 % sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid freeze-thaw cycles.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Short term: 4°C. Long term: Store at -20°C. Avoid freeze-thaw cycles.
-
-
- SNCA (Synuclein, alpha (SNCA))
-
Andere Bezeichnung
- SNCA / alpha-Synuclein
-
Hintergrund
-
Name/Gene ID: SNCA
Synonyms: SNCA, Alpha-synuclein, PARK4, PD1, Synuclein alpha-140, NACP, PARK1 -
Gen-ID
- 6622
-
UniProt
- P37840
-
Pathways
- Synaptic Membrane, Regulation of G-Protein Coupled Receptor Protein Signaling, Positive Regulation of Endopeptidase Activity, Regulation of Carbohydrate Metabolic Process, Platelet-derived growth Factor Receptor Signaling, Negative Regulation of Transporter Activity, Regulation of long-term Neuronal Synaptic Plasticity
Target
-